Geron CorpNASDAQ:GERN
- LAST PRICE4.2200
- TODAY'S CHANGE (%)-0.0300 (-0.7059%)
- Bid / Lots4.2300/ 3
- Ask / Lots4.2700/ 18
- Open / Previous Close4.3000 / 4.2500
- Day Range
- 52 Week Range
- Volume6,027,804
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GERN |
|---|---|---|
| 09:32 ET | 211233 | 4.275 |
| 09:33 ET | 36559 | 4.31 |
| 09:35 ET | 118864 | 4.29 |
| 09:37 ET | 53301 | 4.305 |
| 09:39 ET | 242143 | 4.2645 |
| 09:42 ET | 27280 | 4.259 |
| 09:44 ET | 7962 | 4.245 |
| 09:46 ET | 36178 | 4.21 |
| 09:48 ET | 73023 | 4.165 |
| 09:50 ET | 15851 | 4.155 |
| 09:51 ET | 105359 | 4.1586 |
| 09:53 ET | 25246 | 4.165 |
| 09:55 ET | 34732 | 4.195 |
| 09:57 ET | 57752 | 4.18 |
| 10:00 ET | 4090 | 4.191 |
| 10:02 ET | 19771 | 4.185 |
| 10:04 ET | 16226 | 4.195 |
| 10:06 ET | 40834 | 4.205 |
| 10:08 ET | 11549 | 4.19 |
| 10:09 ET | 4761 | 4.195 |
| 10:11 ET | 4582 | 4.19 |
| 10:13 ET | 46183 | 4.17 |
| 10:15 ET | 34275 | 4.18 |
| 10:18 ET | 23884 | 4.17 |
| 10:20 ET | 23362 | 4.165 |
| 10:22 ET | 4635 | 4.165 |
| 10:24 ET | 22072 | 4.155 |
| 10:26 ET | 336141 | 4.135 |
| 10:27 ET | 13812 | 4.12 |
| 10:29 ET | 5991 | 4.12 |
| 10:31 ET | 134197 | 4.155 |
| 10:33 ET | 18266 | 4.165 |
| 10:36 ET | 19872 | 4.18 |
| 10:38 ET | 18839 | 4.18 |
| 10:40 ET | 2333 | 4.17 |
| 10:42 ET | 29252 | 4.185 |
| 10:44 ET | 4060 | 4.185 |
| 10:45 ET | 16291 | 4.21 |
| 10:47 ET | 32992 | 4.215 |
| 10:49 ET | 29609 | 4.213683 |
| 10:51 ET | 42031 | 4.25 |
| 10:54 ET | 17020 | 4.265 |
| 10:56 ET | 23158 | 4.255 |
| 10:58 ET | 12028 | 4.255 |
| 11:00 ET | 17487 | 4.245 |
| 11:02 ET | 105951 | 4.235 |
| 11:03 ET | 39242 | 4.235 |
| 11:05 ET | 4083 | 4.235 |
| 11:07 ET | 7600 | 4.235 |
| 11:09 ET | 17786 | 4.235 |
| 11:12 ET | 2862 | 4.235 |
| 11:14 ET | 4512 | 4.23 |
| 11:16 ET | 2995 | 4.23 |
| 11:18 ET | 2080 | 4.235 |
| 11:20 ET | 7569 | 4.25 |
| 11:21 ET | 13209 | 4.26 |
| 11:23 ET | 83089 | 4.25 |
| 11:25 ET | 950 | 4.2554 |
| 11:27 ET | 450 | 4.255 |
| 11:30 ET | 2706 | 4.25 |
| 11:32 ET | 2577 | 4.25 |
| 11:34 ET | 12052 | 4.265 |
| 11:36 ET | 20592 | 4.25 |
| 11:38 ET | 2666 | 4.255 |
| 11:39 ET | 1100 | 4.25 |
| 11:41 ET | 7236 | 4.265 |
| 11:43 ET | 3310 | 4.27 |
| 11:45 ET | 5011 | 4.2601 |
| 11:48 ET | 500 | 4.265 |
| 11:50 ET | 16072 | 4.2699 |
| 11:52 ET | 2200 | 4.265 |
| 11:54 ET | 1683 | 4.265 |
| 11:56 ET | 57301 | 4.235 |
| 11:57 ET | 4471 | 4.24 |
| 11:59 ET | 1567 | 4.235 |
| 12:01 ET | 29509 | 4.225 |
| 12:03 ET | 8801 | 4.225 |
| 12:06 ET | 3224 | 4.225 |
| 12:08 ET | 1507 | 4.225 |
| 12:10 ET | 1584 | 4.225 |
| 12:12 ET | 31580 | 4.215 |
| 12:14 ET | 7519 | 4.215 |
| 12:15 ET | 750 | 4.215 |
| 12:17 ET | 17393 | 4.2201 |
| 12:19 ET | 2597 | 4.225 |
| 12:21 ET | 400 | 4.23 |
| 12:24 ET | 3144 | 4.225 |
| 12:26 ET | 5512 | 4.2299 |
| 12:28 ET | 198 | 4.225 |
| 12:30 ET | 2776 | 4.23 |
| 12:32 ET | 2073 | 4.22 |
| 12:33 ET | 77562 | 4.245 |
| 12:35 ET | 6377 | 4.2499 |
| 12:37 ET | 3947 | 4.25 |
| 12:39 ET | 1723 | 4.25 |
| 12:42 ET | 27048 | 4.26 |
| 12:44 ET | 8694 | 4.26 |
| 12:46 ET | 700 | 4.2554 |
| 12:48 ET | 1600 | 4.255 |
| 12:50 ET | 705 | 4.255 |
| 12:51 ET | 26954 | 4.245 |
| 12:53 ET | 8101 | 4.245 |
| 12:55 ET | 5190 | 4.245 |
| 12:57 ET | 3194 | 4.24 |
| 01:00 ET | 4238 | 4.26 |
| 01:02 ET | 100 | 4.26 |
| 01:04 ET | 12892 | 4.25 |
| 01:06 ET | 12830 | 4.2492 |
| 01:08 ET | 8071 | 4.255 |
| 01:09 ET | 6054 | 4.255 |
| 01:11 ET | 2328 | 4.25 |
| 01:13 ET | 1900 | 4.255 |
| 01:15 ET | 1640 | 4.255 |
| 01:18 ET | 3334 | 4.255 |
| 01:20 ET | 5183 | 4.255 |
| 01:22 ET | 10888 | 4.255 |
| 01:24 ET | 2700 | 4.255 |
| 01:26 ET | 4721 | 4.255 |
| 01:27 ET | 1800 | 4.255 |
| 01:29 ET | 4237 | 4.26 |
| 01:31 ET | 32381 | 4.265 |
| 01:33 ET | 14217 | 4.255 |
| 01:36 ET | 59276 | 4.26 |
| 01:38 ET | 2421 | 4.265 |
| 01:40 ET | 13246 | 4.265 |
| 01:42 ET | 10800 | 4.265 |
| 01:44 ET | 4311 | 4.265 |
| 01:45 ET | 8440 | 4.26 |
| 01:47 ET | 18112 | 4.25 |
| 01:49 ET | 7988 | 4.255 |
| 01:51 ET | 2700 | 4.25 |
| 01:54 ET | 10300 | 4.25 |
| 01:56 ET | 3668 | 4.255 |
| 01:58 ET | 16057 | 4.255 |
| 02:00 ET | 15907 | 4.255 |
| 02:02 ET | 2248 | 4.255 |
| 02:03 ET | 48586 | 4.25 |
| 02:05 ET | 22529 | 4.24 |
| 02:07 ET | 6073 | 4.235 |
| 02:09 ET | 2212 | 4.235 |
| 02:12 ET | 2012 | 4.235 |
| 02:14 ET | 2514 | 4.235 |
| 02:16 ET | 13843 | 4.225 |
| 02:18 ET | 900 | 4.22 |
| 02:20 ET | 700 | 4.22 |
| 02:21 ET | 7984 | 4.22 |
| 02:23 ET | 4717 | 4.225 |
| 02:25 ET | 3581 | 4.23 |
| 02:27 ET | 29379 | 4.235 |
| 02:30 ET | 2240 | 4.24 |
| 02:32 ET | 33838 | 4.225 |
| 02:34 ET | 12142 | 4.225 |
| 02:36 ET | 32789 | 4.225 |
| 02:38 ET | 1272 | 4.225 |
| 02:39 ET | 1100 | 4.225 |
| 02:41 ET | 4407 | 4.22 |
| 02:43 ET | 1400 | 4.225 |
| 02:45 ET | 12978 | 4.225 |
| 02:48 ET | 1300 | 4.225 |
| 02:50 ET | 7371 | 4.22 |
| 02:52 ET | 15454 | 4.225 |
| 02:54 ET | 44040 | 4.2432 |
| 02:56 ET | 26581 | 4.255 |
| 02:57 ET | 3781 | 4.255 |
| 02:59 ET | 42758 | 4.255 |
| 03:01 ET | 66566 | 4.255 |
| 03:03 ET | 19452 | 4.245 |
| 03:06 ET | 4286 | 4.24 |
| 03:08 ET | 8366 | 4.24 |
| 03:10 ET | 13652 | 4.24 |
| 03:12 ET | 31465 | 4.255 |
| 03:14 ET | 7119 | 4.25 |
| 03:15 ET | 10766 | 4.255 |
| 03:17 ET | 8725 | 4.255 |
| 03:19 ET | 40533 | 4.255 |
| 03:21 ET | 33685 | 4.245 |
| 03:24 ET | 35308 | 4.23 |
| 03:26 ET | 24333 | 4.23 |
| 03:28 ET | 6856 | 4.235 |
| 03:30 ET | 18115 | 4.23 |
| 03:32 ET | 16847 | 4.235 |
| 03:33 ET | 18468 | 4.235 |
| 03:35 ET | 29562 | 4.235 |
| 03:37 ET | 50081 | 4.235 |
| 03:39 ET | 24930 | 4.2241 |
| 03:42 ET | 22572 | 4.235 |
| 03:44 ET | 11674 | 4.235 |
| 03:46 ET | 34567 | 4.235 |
| 03:48 ET | 12981 | 4.24 |
| 03:50 ET | 22503 | 4.235 |
| 03:51 ET | 101497 | 4.21 |
| 03:53 ET | 97981 | 4.225 |
| 03:55 ET | 112727 | 4.225 |
| 03:57 ET | 95664 | 4.22 |
| 04:00 ET | 955306 | 4.22 |
Today
Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO(TM) (imetelstat) in Myeloid Hematologic Malignancies, from 9 hours ago by Dow Jones
9 hours ago by Dow JonesDJ Geron Initiated at Buy by HC Wainwright & Co., from 9 hours ago by Dow Jones
9 hours ago by Dow Jones
Oct 17, 2024
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Thursday Oct 17, 2024 by Dow Jones
4:30PM ET on Thursday Oct 17, 2024 by Dow Jones
Oct 16, 2024
DJ Geron Price Target Announced at $6.00/Share by Scotiabank, from 10:27AM ET on Wednesday Oct 16, 2024 by Dow Jones
10:27AM ET on Wednesday Oct 16, 2024 by Dow Jones
Oct 15, 2024
Press Release: Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024, from 5:14PM ET on Tuesday Oct 15, 2024 by Dow Jones
5:14PM ET on Tuesday Oct 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Geron Corp | 2.6B | -11.7x | --- |
Scholar Rock Holding Corp | 2.5B | -12.9x | --- |
CG Oncology Inc | 2.5B | -31.6x | --- |
Agios Pharmaceuticals Inc | 2.6B | 3.8x | --- |
IDEAYA Biosciences Inc | 2.5B | -12.7x | --- |
Vera Therapeutics Inc | 2.8B | -21.6x | --- |
Company Information
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Contact Information
- Headquarters
- 919 East Hillsdale Boulevard, Suite 250FOSTER CITY, CA, United States 94404
- Phone
- 650-473-7700
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- John Scarlett
- Chief Financial Officer, Executive Vice President - Finance, Treasurer
- Michelle Robertson
- Executive Vice President, Chief Operating Officer
- Andrew Grethlein
- Chief People Officer, Senior Vice President
- Shannon Odam
- Executive Vice President, Chief Legal Officer, Secretary
- Scott Samuels
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.6B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 602.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.52 |
EPS | $-0.36 |
Book Value | $0.46 |
P/E Ratio | -11.7x |
Price/Sales (TTM) | 1,865.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16,559.94% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
